Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-09

Clinical Trial Update: Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial evaluating arasertaconazole nitrate pessaries for vulvovaginal candidiasis has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arasertaconazole Nitrate Pessaries (arasertaconazole nitrate)

Snippet

Sponsor: Ferrer Internacional S.A. | Conditions: Vulvovaginal Candidiasis | Phase 2 | Status: COMPLETED | Results posted: 2013-10-09